BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16499116)

  • 1. Palliative benefits of chemotherapy treatment in non-small cell lung cancer may be underappreciated.
    J Support Oncol; 2006 Feb; 4(2):61. PubMed ID: 16499116
    [No Abstract]   [Full Text] [Related]  

  • 2. Complexities of quality of life analysis in non-small cell lung cancer.
    Temel J
    J Support Oncol; 2007 Jan; 5(1):30-1. PubMed ID: 17265784
    [No Abstract]   [Full Text] [Related]  

  • 3. Palliative chemotherapy for non-small cell lung cancer: a measured dose of reality.
    Kalemkerian GP
    J Support Oncol; 2007 Jan; 5(1):27-8. PubMed ID: 17265783
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy for lung cancer.
    Locke I; Gillham CM
    N Engl J Med; 2002 May; 346(19):1498; author reply 1498. PubMed ID: 12000824
    [No Abstract]   [Full Text] [Related]  

  • 5. [Benefits of chemotherapy of inoperable non-small cell bronchial cancers].
    Trédaniel J; Lepage E; Marty M; Hirsch A
    Rev Mal Respir; 1990; 7(6):493-5. PubMed ID: 2176731
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic options for elderly patients with advanced non-small cell lung cancer.
    Avery EJ; Kessinger A; Ganti AK
    Cancer Treat Rev; 2009 Jun; 35(4):340-4. PubMed ID: 19155139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer. Chemotherapy.
    Engelking C
    Am J Nurs; 1987 Nov; 87(11):1438-9, 1440-1. PubMed ID: 2823610
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of lung cancer: critical review of new agents].
    Spataro V
    Rev Med Suisse; 2005 Feb; 1(8):575-81. PubMed ID: 15794308
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer.
    Dooms CA; Pat KE; Vansteenkiste JF
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):531-44. PubMed ID: 16613541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new medication for lung cancer].
    Krankenpfl J; 2005; 43(7-10):227. PubMed ID: 16515296
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality trials and quality of life in non-small-cell lung cancer.
    Harper P; Plunkett T; Khayat D
    J Clin Oncol; 2003 Aug; 21(16):3007-8. PubMed ID: 12837809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
    Socinski MA
    J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
    [No Abstract]   [Full Text] [Related]  

  • 14. Palliative chemotherapy: do we need yet another end-point?
    van Meerbeeck JP; Baas P
    Eur J Cancer; 2009 Sep; 45(13):2234-5. PubMed ID: 19524432
    [No Abstract]   [Full Text] [Related]  

  • 15. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
    Bearz A; Serraino D; Fratino L; Berretta M; Tirelli U
    Cancer; 2007 Dec; 110(11):2593-4; author reply 2594. PubMed ID: 17960771
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
    Tanaka F; Wada H
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of gastrointestinal carcinomas and non-small-cell pulmonary carcinoma: a controversy].
    Fey MF; Sauter C; Alberto P
    Schweiz Med Wochenschr; 1996 May; 126(20):872-8. PubMed ID: 8685683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foreword--new directions for topotecan in lung cancer treatment.
    Stewart DJ
    Oncologist; 2004; 9 Suppl 6():1-3. PubMed ID: 15616144
    [No Abstract]   [Full Text] [Related]  

  • 20. The management of PS2 patients with advanced non-small cell lung cancer.
    Cheong KA; Chrystal K; Harper PG
    Int J Clin Pract; 2006 Nov; 60(11):1493-6. PubMed ID: 16911572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.